The Knight Diagnostic Laboratories (KDL) were formed under the Knight Cancer Institute in January 2011 through a merger of four hospital laboratories located within Oregon Health & Sciences University (OHSU) in Portland, Oregon.  These laboratories include a molecular translational research lab from pathology, along with three genetics laboratories specializing in molecular genetics, cytogenetics, FISH and biochemical analyses.  KDL’s nationally known Medical Directors all hold academic appointments with OHSU and have decades of experience in test development, validation, diagnostic testing and consultation.

The Knight Diagnostic Laboratories provide advanced laboratory testing services, as well as research and development services, for healthcare providers and pharmaceutical clients in the rapidly growing field of molecular medicine.   The KDL provides a comprehensive menu of oncology, infectious disease, and rare genetic disorder tests designed to help physicians deliver individualized, specific and accurate diagnoses and treatment decisions.

The Knight Diagnostic Laboratories participate in training programs with the OHSU Department of Molecular and Medical Genetics and the Department of Pathology.   Fellows learn both technical and interpretive aspects of current testing as well as participation in bringing new tests and platforms into clinical use.

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More